News & Press: Advocacy

SIS Comments on Majoris Guidelines that Exclude Some Cervical ESIs

Monday, October 17, 2016  
On October 6, SIS submitted comments to Majoris Health Systems on their treatment guidelines for epidural steroid injections. The comments focused specifically on the current policy’s exclusion of cervical ESIs, with the exception of transforaminal ESIs at the C6-C7 level using non-particulate steroid formulations. To see the letter, click here.